Akynzeo 300 mg/0.5 mg hard capsules clinical trials

A Phase 2 Open-label, multicenter study to evaluate efficacy and safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma

This study is testing a new medicine, ZN-c3, for women with a type of womb cancer called uterine serous carcinoma that has come back or is still present. It aims to see how well the medicine works and if it has any side effects.